Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/120436
Title: | The role of multimodal treatment in Crohn′s disease patients with perianal fistula : a multicentre retrospective cohort study |
Authors: | Sebastian, Shaji Black, Christopher Pugliese, Daniela Armuzzi, Alessandro Sahnan, Kapil Elkady, Soad M. Katsanos, Kostas H. Christodoulou, Demitrios K. Selinger, Christian Maconi, Giovanni Fearnhead, Nicola S. Kopylov, Uri Davidov, Yana Bosca-Watts, Marta M. Ellul, Pierre Muscat, Martina Karmiris, Konstantinos Hart, Ailsa L. Danese, Silvio Ben-Horin, Shomron Fiorino, Gionata |
Keywords: | Inflammatory bowel diseases Crohn's disease Anal fistula Combined modality therapy Therapeutics |
Issue Date: | 2018 |
Publisher: | Wiley-Blackwell Publishing Ltd |
Citation: | Sebastian, S., Black, C., Pugliese, D., Armuzzi, A., Sahnan, K., Elkady, S. M.,...Fiorino, G. (2018). The role of multimodal treatment in Crohn′ s disease patients with perianal fistula: a multicentre retrospective cohort study. Alimentary Pharmacology & Therapeutics, 48(9), 941-950. |
Abstract: | Background: Treatment paradigms for Crohn′s disease with perianal fistulae (CD‐ pAF) are evolving. Aims: To study the impact of multimodality treatment in CD‐pAF on recurrence rates and the need for re‐interventions and to identify predictive factors for these outcomes. Methods: This was a multinational multicentre retrospective cohort study. Multimodality approach was defined as using a combination of medical treatments (anti‐TNFs ± immunomodulators ± antibiotics) along with surgical approach (examination under anaesthesia (EUA) ± seton drainage) at diagnosis of CD‐pAF. Univariable and multivariable analyses were performed for variables indicative of the need for reintervention. Results: A total of 253 patients were included. 65% of patients received multimodality approach. Multimodality treatment resulted in complete fistula healing in 52% of patients. Re‐intervention was needed in 27% of patients with simple and in 40.3% of those with complex fistula. On multivariable analysis multimodality treatment (OR: 0.35, 95% CI: 0.17‐0.57, P = 0.001), seton removal (OR: 0.090, 95% CI: 0.027‐0.30, P = 0.0001, therapy with infliximab (OR: 0.19, 95% CI: 0.06‐0.64, P = 0.007), and therapy with adalimumab (OR: 0.12, "95% CI: 0.026‐0.56, P = 0.007) were predictive of avoiding repeat surgery. Proctitis (OR: 3.76, 95% CI: 1.09‐12.96, P = 0.03) was predictive of the need for radical surgery (proctectomy, diverting stoma) while multimodality treatment reduced the need for radical surgery (OR: 0.21, 95% CI: 0.05‐0.81, P = 0.02). Conclusions: Multimodality treatment, anti‐TNFs use, and removal of setons after multimodality treatment can result in improved outcomes in CD patients with peri-anal fistulae and reduce the need for repeat surgery and radical surgery. |
URI: | https://www.um.edu.mt/library/oar/handle/123456789/120436 |
Appears in Collections: | Scholarly Works - FacM&SMed |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
The_role_of_multimodal_treatment_in_Crohns_disease_patients_with_perianal_fistula_a_multicentre_retrospective_cohort_study_2018.pdf Restricted Access | 674.17 kB | Adobe PDF | View/Open Request a copy |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.